MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
OrcaBio
Organization & Developments: Orca Bio
Parents
OrcaBio
Children
2020: Orca Bio Emerges With Nearly $300 Million to Transform Allogeneic Cell Therapy
2020: Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies_xconomy
Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases
Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and autoimmune disorders
High precision cell therapies manufactured by Orca Bio have the potential to replace conventional bone marrow transplants and expand the eligible patient population
Jumps
Finance & Acquisitions: Orca Bio
Key People: Orca Bio